SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Quidel plans initial release to professional and point-of-care segments with a goal of expansion to serve telemedicine and home markets Sofia Q is the latest product in Quidel’s best-selling Sofia ...
Nevada has suspended the use of two rapid COVID-19 tests in nursing homes after the tests repeatedly delivered false-positives, according to an Oct. 2 directive issued by the state health department.
Since the start of the pandemic, the FDA has issued emergency use authorizations to a whopping 444 diagnostic tests and sample collection devices to detect the COVID-19 virus. In recent months, ...
The FDA’s emergency use authorization (EUA) program for rapid antigen tests for the COVID-19 pandemic is coming to an end, but few rapid antigen test makers have laid out clear plans regarding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results